In an interview to CNBC-TV18, Vivek Siddharth, COO of Caplin Point Laboratories discussed the company's Q2 performance.
We should be able to achieve the guidance that we had given last year which is about 20-25 percent, said Siddharth.
Talking about margins, he said we have got into unique segment in the last 12 months like pharma over-the-counter (OTC), soft gel and wellness category. Therefore, margins and the market we are entering in are a lot more profitable than before.
Watch accompanying video for more details.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!